325855-74-1: Etoricoxib N1-Oxide
It is a COX-2 selective inhibitor along with anti-inflammatory, analgesic properties and also possesses antineoplastic properties.
Additional information on CAS 325855-74-1
Catalogue No.
VE006603
CAS No.
325855-74-1
Molecular Formula
C18H15ClN2O3S
Molecular Weight
374.84
Parent drug
Etoricoxib
IUPAC Name
5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2, 3'-bipyridine 1'-oxide
Synonyms
N/A
References
“A Comparative Study of Aceclofenac versus Etoricoxib in the Management of Acute Low Back Pain in a Tertiary Care Hospital.” Journal of Drug Assessment, 2020, http://www.tandfonline.com/doi/full/10.1080/21556660.2020.1734008.
Status
In-stock
